Neurologic diseases and disorders are now the leading cause of disability nationwide, affecting half the US population. A systematic analysis showed that 1 in 2 people, ie, nearly half the US ...

The FDA approved the intrathecal gene therapy onasemnogene abeparvovec (Itvisma) to treat spinal muscular atrophy (SMA) in adults and pediatric patients 2 years and older with a confirmed mutation in ...

Equine herpes myeloencephalopathy (EHM) has been detected in states surrounding New Mexico, and horses from New Mexico could have come into contact with the virus at events in Texas and Oklahoma.

One in two people in the United States, just over half of the population, is affected by a neurological disease or disorder, according to a new systematic analysis by the American Academy of Neurology ...

Those with the sleep condition were more likely to develop Parkinson’s disease. But one treatment was found to help. By Caroline Hopkins Legaspi In a study published Monday in JAMA Neurology, ...

An Australian woman has decided to end her life with medical assistance to “die on her own terms” after years of living with a rare and terminal neurological disease. Annaliese Holland, 25, said she ...

A team of researchers at Massachusetts Institute of Technology (MIT) has been refining and combining several advanced technologies over the past six years to create a revolutionary platform to treat a ...

Search teams fanned out through the dense woods of Dorchester, New Hampshire, and the sun was starting to set. Temperatures dropped below 40 degrees as volunteers scoured the area for a 2-year-old ...

Ionis Pharmaceuticals IONS announced positive topline results from a pivotal phase III study evaluating its investigational RNA-targeted therapy zilganersen for treating a rare neurological condition ...

Ionis Pharmaceuticals is eyeing a new rare disease approval after its antisense oligonucleotide zilganersen successfully improved mobility in patients with the neurological condition Alexander disease ...